Skip to content
Screener

Exelixis EXEL Business Segments — Interest Income

Similar metrics at other companies

Anterix logo
ATEXReportable Segment — Interest Income
$472K+5.8%
Marqeta logo
MQReportable Segment — Interest Income
$5.36M-48.9%
Arcutis Biotherapeutics, Inc. logo
ARQTReportable Segment — Interest Income
$2.28M+9.8%
Tarsus Pharmaceuticals, Inc. logo
TARSReportable Segment — Interest Income
$3.7M-12.6%
Century Aluminum logo
CENXReportable Segment — Interest Income
$4.4M+132%
Douglas Elliman logo
DOUGOne Reportable Segment — Interest Income
$890K-34.6%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeOther.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Cost of goods sold20,65719,47040,61038,642
Drug discovery18,25221,35737,72839,610
Development150,522134,159286,237287,376
Selling, general, and administrative127,413112,931250,283233,706
Other segment items(1)63,37866,718124,616124,134
Interest income(14,210)(16,789)(30,337)(35,865)
Provision for income taxes50,62845,567107,84891,641
Segment and consolidated net income$212,050$184,848$422,517$344,464

Item 1. Financial Statements.

FAQ

What is Exelixis's business segments — interest income?
Exelixis (EXEL) reported business segments — interest income of $14.21M in Q2 2026.
How has Exelixis's business segments — interest income changed year-over-year?
Exelixis's business segments — interest income decreased by 15.4% year-over-year, from $16.79M to $14.21M.
What is the long-term trend for Exelixis's business segments — interest income?
Over 3 years (2022 to 2025), Exelixis's business segments — interest income has grown at a 27.9% compound annual growth rate (CAGR), from $33.07M to $69.21M.
What does business segments — interest income mean?
Represents the income earned on the company's cash, cash equivalents, and marketable securities. This reflects the yield on the company's treasury management and liquidity position.

Ask your AI about Exelixis's business segments — interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude